OrphanDrug
OrphanDrug
Pharma Knowledge Base

hyper-IgD syndrome

ORPHA: 343

Contents

  1. 1. Available Treatments
  2. 2. Clinical Presentation
  3. 3. Classification & Codes

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with hyper-IgD syndrome, sourced from HPO and Orphanet clinical annotations.

PurpuraUrticariaAcrocyanosisSeizureAtaxiaGlobal developmental delayArthritisLimitation of joint mobilityGrowth delayRecurrent feverDiarrheaAbdominal painMigraineGastrointestinal hemorrhageHepatomegalyPeritonitisVasculitisLymphadenopathyArthralgiaIncreased circulating IgA concentrationMyalgiaElevated erythrocyte sedimentation rateIntestinal obstructionErythemaRecurrent aphthous stomatitisPapule

Classification & Codes

Orphanet Code

ORPHA:343
hyper-IgD syndrome
OrphanetORPHA:343
Treatments0 drug(s)
Symptoms on record26 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO